A new outcomes-based contract between Harvard Pilgrim Health Care and prenatal testing provider Illumina includes a commitment by the company to fund a two-year real-world study on the cost savings provided by expanded access to the test.
The research component of the arrangement makes it potentially relevant for pharma, Harvard Pilgrim Health Care Chief Medical Officer Michael...







